Crescent Diagnostics Ltd. (Crescent Diagnostics) is a medical device company engaged in the field of orthopedics, developing a new biomarker Bone Quality Test (BQT). It is conducting a range of clinical trials in partnership with hospitals in the UK and Ireland to expand the clinical evidence underlying this technology. The new biomarker uses Raman spectroscopy to analyze the human fingernail and assess bone health. It is useful for accurate prediction of bone fracture risk. Crescent Diagnostics has a comprehensive Intellectual Property portfolio covering the biomarker and its application. The company owns its research office at Limerick, Ireland. Crescent Diagnostics is headquartered at London, the UK.